Form 4: Viemed Healthcare President's Equity Activity

Viemed Healthcare's President, Michael Moore, reported significant equity transactions including RSU and phantom share vesting, tax-related dispositions, and new equity grants.

Summary

• Michael Moore, President of Viemed Healthcare, Inc. (VMD), reported changes in beneficial ownership through a Form 4 filing.
• On January 17, 2026, Moore acquired 26,939 common shares from the vesting of previously granted Restricted Stock Units (RSUs) and 6,735 common shares from the vesting of Phantom Share Units.
• Concurrently, 8,548 common shares were disposed of to satisfy tax obligations arising from RSU vesting, and 6,735 common shares were disposed of for cash settlement of phantom shares, both at a per-share value of $7.33.
• Following these transactions, Moore directly beneficially owned 144,734 common shares.
• Moore also indirectly beneficially owned 1,722,614 common shares through Moore Faster LLC.
• On January 19, 2026, Moore received new equity awards consisting of 118,759 Restricted Stock Units and 29,690 Phantom Share Units.
• These newly granted RSUs and Phantom Share Units are scheduled to vest in three equal annual installments, with the first installment occurring on January 19, 2027.

Sentiment

Score: 5

Explanation: This is a routine insider transaction report detailing equity compensation vesting, tax-related dispositions, and new grants. It does not inherently convey positive or negative sentiment about the company's performance or outlook, but rather reflects standard executive compensation practices.

Positives

• The grant of 118,759 new Restricted Stock Units and 29,690 Phantom Share Units aligns the President's long-term interests with those of shareholders.
• Continued significant equity participation by a key executive demonstrates ongoing commitment to the company.

Negatives

• Disposition of 8,548 common shares to cover tax obligations related to RSU vesting.
• Disposition of 6,735 common shares for the cash settlement of phantom shares.

Future Outlook

New Restricted Stock Units and Phantom Share Units granted on January 19, 2026, are scheduled to vest in three equal annual installments, commencing on January 19, 2027, and expiring on January 19, 2029.

Industry Context

NA

Stakeholder Impact

• Shareholders: Indicates continued equity alignment of a key executive with shareholder interests through new grants, while also showing routine dispositions for tax and cash settlement.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Future vesting of 118,759 Restricted Stock Units in three equal annual installments starting January 19, 2027.
• Future vesting of 29,690 Phantom Share Units in three equal annual installments starting January 19, 2027.

Key Dates

Keywords

Viemed Healthcare, VMD, Michael Moore, President, SEC Form 4, Insider Trading, Beneficial Ownership, Restricted Stock Units, RSU, Phantom Share Units, Equity Compensation, Stock Vesting, Tax Withholding